Cartilage diseases

Y Krishnan, AJ Grodzinsky - Matrix Biology, 2018 - Elsevier
Hyaline cartilages, fibrocartilages and elastic cartilages play multiple roles in the human
body including bearing loads in articular joints and intervertebral discs, providing joint …

Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison

J Feld, V Chandran, N Haroon, R Inman… - Nature Reviews …, 2018 - nature.com
Ankylosing spondylitis (AS) was first identified in the late 17th century. 250 years later,
inflammatory spine disease was recognized to be one of the patterns of psoriatic arthritis …

Signaling pathways and targeted therapies for psoriasis

J Guo, H Zhang, W Lin, L Lu, J Su… - Signal Transduction and …, 2023 - nature.com
Psoriasis is a common, chronic, and inflammatory skin disease with a high burden on
individuals, health systems, and society worldwide. With the immunological pathologies and …

[HTML][HTML] Psoriasis and co-morbidity

A Mina, T Tsen-Fang - Acta dermato-venereologica, 2020 - ncbi.nlm.nih.gov
Psoriasis is associated with multiple co-morbid medical conditions. The purpose of this study
is to evaluate the relationships between psoriasis and cardiovascular disease, psoriatic …

Safety and efficacy of intravenous golimumab in patients with active psoriatic arthritis: results through week twenty‐four of the GO‐VIBRANT study

A Kavanaugh, ME Husni, DD Harrison… - Arthritis & …, 2017 - Wiley Online Library
Objective To evaluate the safety and efficacy of intravenous (IV) golimumab treatment in
psoriatic arthritis (PsA). Methods In this phase III, randomized, double‐blind, placebo …

Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis

A Ruyssen-Witrand, R Perry, C Watkins, G Braileanu… - RMD open, 2020 - rmdopen.bmj.com
Background Biologic disease-modifying antirheumatic drugs (bDMARDs) and targeted
synthetic DMARDs are used in patients with psoriatic arthritis (PsA), but few studies directly …

Skin manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritides

CJ Chua-Aguilera, B Möller, N Yawalkar - Clinical reviews in allergy & …, 2017 - Springer
Extra-articular manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and various
spondyloarthritides including psoriatic arthritis, ankylosing spondylitis, reactive arthritis, and …

Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis

S Sarabia, B Ranjith, S Koppikar, DT Wijeratne - BMC rheumatology, 2022 - Springer
Background JAK inhibitors are a relatively new class of medications that may be useful in
the treatment of moderate-to-severe psoriasis and psoriatic arthritis (PsA). The objective of …

Cimifugin relieves pruritus in psoriasis by inhibiting TRPV4

J Yan, F Ye, Y Ju, D Wang, J Chen, X Zhang, Z Yin… - Cell Calcium, 2021 - Elsevier
Psoriasis is an immune-mediated chronic inflammatory skin disease characterized by
erythema, scales, and infiltration of the skin, which causes deleterious effects on patient …

Omics and multi-omics analysis for the early identification and improved outcome of patients with psoriatic arthritis

R Gurke, A Bendes, J Bowes, M Koehm, RM Twyman… - Biomedicines, 2022 - mdpi.com
The definitive diagnosis and early treatment of many immune-mediated inflammatory
diseases (IMIDs) is hindered by variable and overlapping clinical manifestations. Psoriatic …